4.3 Review

CTLA-4 blockade in the treatment of rheumatoid arthritis: an update

Related references

Note: Only part of the references are listed.
Article Pharmacology & Pharmacy

Rheumatoid Arthritis: An Evolutionary Force in Biologics

Philip M. Brown et al.

CURRENT PHARMACEUTICAL DESIGN (2015)

Article Biotechnology & Applied Microbiology

Subcutaneous abatacept in rheumatoid arthritis: current update

Edward Keystone et al.

EXPERT OPINION ON BIOLOGICAL THERAPY (2015)

Review Biochemistry & Molecular Biology

Recent progress and perspective in JAK inhibitors for rheumatoid arthritis: from bench to bedside

Yoshiya Tanaka

JOURNAL OF BIOCHEMISTRY (2015)

Article Multidisciplinary Sciences

Functional Characterization of Human T Cell Hyporesponsiveness Induced by CTLA4-Ig

Yrina Rochman et al.

PLOS ONE (2015)

Editorial Material Rheumatology

Chronobiology and the treatment of rheumatoid arthritis

Maurizio Cutolo

CURRENT OPINION IN RHEUMATOLOGY (2012)

Review Medicine, General & Internal

MECHANISMS OF DISEASE The Pathogenesis of Rheumatoid Arthritis

Iain B. McInnes et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Review Rheumatology

Abatacept treatment for rheumatoid arthritis

Michael Schiff

RHEUMATOLOGY (2011)

Review Rheumatology

Evaluation of abatacept in biologic-naive patients with active rheumatoid arthritis

Michael Schiff et al.

CLINICAL RHEUMATOLOGY (2010)

Article Immunology

B7-1/2 (CD80/CD86) Direct Signaling to B Cells Enhances IgG Secretion

Friederike C. Rau et al.

JOURNAL OF IMMUNOLOGY (2009)

Article Rheumatology

CTLA-4 directly inhibits osteoclast formation

R. Axmann et al.

ANNALS OF THE RHEUMATIC DISEASES (2008)

Article Immunology

Expression of CD86 on Human Islet Endothelial Cells Facilitates T Cell Adhesion and Migration

Biliana Lozanoska-Ochser et al.

JOURNAL OF IMMUNOLOGY (2008)

Article Immunology

Dermal fibroblasts induce maturation of dendritic cells

Anja Saalbach et al.

JOURNAL OF IMMUNOLOGY (2007)